Your browser doesn't support javascript.
loading
Advantage of extracellular vesicles in hindering the CD47 signal for cancer immunotherapy.
Kim, Yoon Kyoung; Hong, Yeonsun; Bae, Young Rang; Goo, Jiyoung; Kim, Seong A; Choi, Yoonjeong; Nam, Gi-Hoon; Kwon, Minsu; Yun, Seung Gyu; Lee, Gyejun; Jeong, Cherlhyun; Kim, In-San.
Affiliation
  • Kim YK; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Hong Y; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Bae YR; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Goo J; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul, 02447 Seoul, Republic of Korea.
  • Kim SA; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Choi Y; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Nam GH; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Kwon M; Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.
  • Yun SG; Department of Laboratory Medicine, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
  • Lee G; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul, 02447 Seoul, Republic of Korea.
  • Jeong C; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; KHU-KIST Department of Converging Science and Technology, Kyung Hee University, Seoul, 02447 Seoul, Republic of Korea; Division o
  • Kim IS; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea; Chemical & Biological Integrative Research Center, Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea. Electronic addres
J Control Release ; 351: 727-738, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36162554
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Vesicles / Neoplasms Limits: Humans Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Extracellular Vesicles / Neoplasms Limits: Humans Language: En Journal: J Control Release Journal subject: FARMACOLOGIA Year: 2022 Type: Article